Abbott India EBITDA
Mi az Abbott India EBITDA?
A EBITDA az Abbott India Limited - ₨10.524B
Mi a EBITDA meghatározása?
Az EBITDA a társaság kamat, adózás, értékcsökkenés és amortizáció előtti eredmény, és a társaság nettó eredménye alapján számított számviteli intézkedés, a kamatkiadások, az adók, az értékcsökkenés és az amortizáció levonása előtt, a vállalat jelenlegi működési nyereségességének alapjaként.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA a Health Care szektor a NSE-on cégekben a Abbott India -hoz képest
Mit csinál Abbott India?
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
ebitda -hoz hasonló cégek Abbott India
- UBS AG nak EBITDA $10.450B van
- Jiangxi Copper nak EBITDA ¥10.488B van
- Fortescue Metals nak EBITDA $10.502B van
- Fortescue Metals nak EBITDA $10.502B van
- Fortescue Metals nak EBITDA $10.502B van
- Orient Overseas (International) nak EBITDA $10.516B van
- Abbott India nak EBITDA ₨10.524B van
- Linde Plc nak EBITDA $10.552B van
- Fedex Corp nak EBITDA $10.585B van
- Axa Nv20 nak EBITDA €10.603B van
- Jindal Poly Investment and Finance nak EBITDA ₨10.616B van
- Indian Railway Catering & Tourism nak EBITDA ₨10.638B van
- Barclays plc nak EBITDA £10.644B van